Skip to content
Menu
About
Current Projects
Board of Directors
Our Team
Partners and Funders
Careers
Contact Us
Publications
Surveys
Cover Michigan Survey
Michigan Physician Survey
Publications
Survey Methodology
Survey Services
Fellowships
CHRT Health Policy Fellowship
2024 Policy Fellows
Apply
Alumni
Curriculum
Sponsors
DHD Fellowship
2023 DHD Fellows
Inaugural DHD Fellowship Graduates
Impact
15th Anniversary Timeline
Our Strategy for Action and Impact
2023 Impact Report
2022 Impact Report
2021 Impact Report
2020 Impact Report
2019 Impact Report
Integration resource hub
Services
Integration
Program Evaluation
Policy Analysis
Surveys and Data Collection
Health and Social Equity
Communications
Presentations
News
CHRT in the News
For the Media
CHRT News
CHRT E-news
CHRT Blog
Presentations
Intranet
Ask CHRT
News
Publications >
Search for:
Navigate to a topic
Select a topic...
Affordable Care Act
Healthy Aging
Integration
Medicaid
Mental Health
Substance Use
Coronavirus
Disability
Health Equity
Behavioral Health
Ex-pharma CEO Martin Shkreli defends EpiPen price increase
August 25, 2016 | In The Media, USA Today
